Search

Your search keyword '"Fernández-Capitán, C"' showing total 178 results

Search Constraints

Start Over You searched for: Author "Fernández-Capitán, C" Remove constraint Author: "Fernández-Capitán, C"
178 results on '"Fernández-Capitán, C"'

Search Results

1. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

2. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

3. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

4. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

5. COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding

6. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

7. Enoxaparin versus dalteparin or tinzaparin in patients with cancer and venous thromboembolism: The RIETECAT study

8. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

9. Timing and characteristics of venous thromboembolism after noncancer surgery

11. Comparative clinical prognosis of massive and non‐massive pulmonary embolism: A registry‐based cohort study

12. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

13. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

14. Age-Related Differences in the Presentation, Management, and Clinical Outcomes of 100,000 Patients With Venous Thromboembolism in the RIETE Registry

15. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

16. A prognostic score to identify women at increased risk for abnormal uterine bleeding during anticoagulation for venous thromboembolism

19. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

20. Venous thromboembolism characteristics, treatment and outcomes in young adults: findings from the Registro Informatizado de Enfermedad TromboEmbólica registry

21. Clinical outcomes during anticoagulant therapy in fragile patients with venous thromboembolism

22. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

23. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

24. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site

25. Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry

26. DVT Management and Outcome Trends, 2001 to 2014

27. A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

28. A prognostic score to identify low‐risk outpatients with acute deep vein thrombosis in the upper extremity

29. Subsequent arterial ischemic events in patients receiving anticoagulant therapy for venous thromboembolism

31. Bleeding risk in hospitalized patients with COVID‐19 receiving intermediate‐ or therapeutic doses of thromboprophylaxis

32. Development of a Risk Prediction Score for Occult Cancer in Patients With VTE

33. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

34. Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism

35. Timing and characteristics of venous thromboembolism after noncancer surgery

36. A Prognostic Score to Identify Low-risk Outpatients with Acute Deep Vein Thrombosis in the Lower Limbs

38. First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry

40. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry

41. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

42. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation

43. Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism

45. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis

46. Outcomes in Neurosurgical Patients Who Develop Venous Thromboembolism

47. D-dimer levels and 90-day outcome in patients with acute pulmonary embolism with or without cancer

48. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism

49. Early use of echocardiography in patients with acute pulmonary embolism: Findings from the RIETE registry

50. Validation of a score for predicting fatal bleeding in patients receiving anticoagulation for venous thromboembolism

Catalog

Books, media, physical & digital resources